Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1989 Oct;28(4):493–494. doi: 10.1111/j.1365-2125.1989.tb03532.x

An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá.

T D Arias, L F Jorge
PMCID: PMC1380002  PMID: 2590609

Full text

PDF
493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arias T. D., Inaba T., Cooke R. G., Jorge L. F. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway. Clin Pharmacol Ther. 1988 Sep;44(3):343–352. doi: 10.1038/clpt.1988.160. [DOI] [PubMed] [Google Scholar]
  2. Arias T. D., Jorge L. F., Lee D., Barrantes R., Inaba T. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers. Clin Pharmacol Ther. 1988 Apr;43(4):456–465. doi: 10.1038/clpt.1988.58. [DOI] [PubMed] [Google Scholar]
  3. Inaba T., Arias T. D. On phenotyping with isoniazid: the use of urinary acetylation ratio and the uniqueness of antimodes. Study of two Amerindian populations. Clin Pharmacol Ther. 1987 Nov;42(5):493–497. doi: 10.1038/clpt.1987.186. [DOI] [PubMed] [Google Scholar]
  4. Iyun A. O., Lennard M. S., Tucker G. T., Woods H. F. Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation. Clin Pharmacol Ther. 1986 Oct;40(4):387–394. doi: 10.1038/clpt.1986.195. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES